Parogencyl Control toothpaste

Parogencyl is a specialized oral care brand long recognized in the European market, particularly in Spain and France, for its therapeutic solutions targeting gum health and gingivitis prevention.

Originally developed by Laboratorios Almirall in Spain, the brand gained a reputation for its pharmaceutical-grade formulations. For many years, it was part of the GSK (GlaxoSmithKline) portfolio under their consumer healthcare division.

Following the major 2022 demerger of GSK's consumer health business, the brand transitioned into the ownership of Haleon. Haleon is a leading global consumer health company headquartered in the United Kingdom, managing a vast array of well-known brands across oral care, pain relief, and respiratory health.